Investorideas.com

Get great ideas from our AI, cannabis, cleantech, crypto, esports and mining podcasts - be a guest or sponsor : 800 665 0411


Share on StockTwits

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 504 (TSXV: KHRN), (NASDAQ: NEPT) (TSX: NEPT), (TSXV: WMD), (CSE: RWB)

 

Delta, Kelowna, BC - December 7, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/120720-StocksToWatch.mp3

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 504 (TSXV: KHRN), (NASDAQ: NEPT) (TSX: NEPT), (TSXV:WMD), (CSE: RWB)

SHARE PODCAST:      

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

Today's podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today's podcast we will be looking at a few private and public company announcements.

Khiron Life Sciences Corp. (TSXV: KHRN), (OTCQX: KHRNF), a vertically integrated cannabis leader with core operations in Latin America and Europe, announced that as a result of strong clinical evidence, the Company's National Strategic Project status, and a directive from the Government of Colombia, its medical cannabis products and clinic services are now covered by the country's major health insurance providers, including medical cannabis as a first line therapy. In Colombia more than 94% of the population have health insurance.

"We see the inclusion of our products and services under health insurance policies as a significant driver of revenue opportunities for Khiron in Colombia, and a validation of our clinic model and the potential for market growth in the country. Importantly, this will allow more Colombians access to benefit from our medical cannabis products and clinic resources," commented Alvaro Torres, Khiron CEO and Director.

"Since becoming the first company to fill cannabis prescriptions in Colombia, 92% of our patients have reported an improvement in their primary conditions after four months of treatment with Khiron products. We look forward to improving the quality of life of even more patients who are now able to access medical cannabis through insurance coverage," added Mr. Torres.

With today's news, Colombia joins an exclusive list of countries offering health insurance coverage for medical cannabis, including Germany and the Czech Republic. In the first half of 2020, over €75 million worth of medical cannabis products were sold in Germany to an estimated patient population of approximately 120,000 (Source: Prohibition Partners). Revisions to German laws in 2017 had wide ranging implications for the country's cannabis market requiring health insurers to cover the costs of the prescription except in exceptional circumstances, with over 60% of patients receiving reimbursement from their health insurance provider. In the Czech Republic, which recently included extended health insurance for medical cannabis, sales in the first four months of 2020 increased threefold over the same period in 2019.

Under the Colombian program, Khiron clinics receive government and insurance company authorization to fill patient prescriptions for magistral preparations; subsequently, the Company is reimbursed once products have been dispensed to the patients. This will allow a greater number of Colombian patients to have access to Khiron's medical cannabis products and clinical services. Khiron's clinic strategy continues to provide cost-effective access to patients, while allowing the Company to generate medical evidence and deliver an unparalleled physician and patient experience. With a large patient base and growing network of physicians trained in the prescription of medical cannabis, Khiron is uniquely positioned to take advantage of the insurance policy change.

Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated health and wellness company focused on natural, plant-based, sustainable and purpose-driven lifestyle brands, made the following statement regarding the More Act, that was passed today by the U.S. Congress.

This legislation marks the first time either chamber of Congress in the United States has voted to federally decriminalize cannabis. Michael Cammarata, Neptune Wellness Chief Executive Officer, said:

"We salute the United States government as they embrace the innovation that companies such as Neptune are accomplishing daily. We are readying the Company for future expansion in adult use-cannabis and global hemp, beginning in the United States with the potential for legalization of cannabis under President-Elect Joe Biden."

"We believe the future of creating health and wellness benefits for consumers across North America and worldwide will be found in plant-based solutions such as those being developed by Neptune Wellness. Our diversified and fully integrated business model focuses on natural, plant-based, sustainable, and purpose-driven lifestyle brands and the use of cannabinoids in household products to make them safer, healthier, and more effective."

"If and when legalization occurs, we intend to bring our Mood Ring product to the United States. This cannabis innovation follows Neptune's first commercial production of hashish (or hash) - comprised of extracted cannabis trichomes utilizing its proprietary technologies at the Company's purpose-built facility in Sherbrooke, Quebec. In the U.S., Neptune believes our unique product offerings will likewise position the Company to enter what will be a highly lucrative market and to meet consumer demand with market-leading, dependable and responsible 'Made in the USA' brands."

Neptune has announced it is opening a Florida-based office in 2021 to focus on U.S. legislation matters in cannabis and global growth opportunities. This office will lead the Company's international institutional advocacy program to drive the conversion of cannabis from an illicit to the regulated market.

The Company already has a 24,000-square-foot facility in Conover, North Carolina, for the production of branded product.

WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF), a federally-licensed producer and distributor of medical-grade cannabis, announced that it has commenced shipping its newest cultivar Black Sugar Rose to the Ontario Cannabis Store for sale to provincial retailers under the Company's Color Cannabis adult-use brand.

As WeedMD's first cultivar to carry a terpene profile listing, the indica-dominant hybrid whole flower product is currently available with a terpene profile of 3.6 per cent and THC level of 20 per cent. Packaged in nitrogen-flushed, Color-branded pouches, the Company is responding to the call for new cultivars, flower integrity, greater product diversity and less packaging. The move is also part of the Company's commercial growth plan to enhance market appeal for its Color Cannabis brand and accommodate an ever-evolving, discerning national consumer base.

"Cannabis retailers and consumers are increasingly aware that cannabinoids only tell a part of a flower's story," said Angelo Tsebelis, Chief Executive Officer. "By adding terpene listings on our Color brands, we are providing consumers with important product data and information that will enhance their cannabis acumen and empower them to make more informed purchase decisions. Black Sugar Rose packs an impressive 3.6 per cent total terpenes and showcases our cultivation team's time-tested commitment to quality-production."

"Cultivating and releasing Black Sugar Rose in Ontario is a proud achievement and pays homage to WeedMD's cultivation pedigree and tradition for excellence," said Curtis Wallace, Head of Cultivation. "In selecting new cultivars, we took great care to complement our carefully selected Color Cannabis genetics and product line. This cultivar's terpene and cannabinoid profile stands up alongside some of our most iconic cultivars, including our exclusively held, top-selling Pedro's Sweet Sativa."

Terpenes are organic compounds that make up the aroma and flavour of specific cultivars. Studies suggest that total terpene percentages dictate the intensity of aroma and potential to modify effects of cannabinoids. Moving forward, WeedMD expects to list total terpenes of each Color-branded dried flower product on its new packaging.

The Company also announced it has agreed to part ways with Stephen Ng as Chief Commercial Officer effective immediately. "On behalf of the Company, we thank Stephen for his many contributions during the build-up of Starseed Medicinal and its integration into WeedMD," said Mr. Tsebelis. "Stephen was instrumental in shaping our business as we prepare to enter the next phase of our growth. We wish him the very best in his future endeavours."

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) announced a phase one roll-out of an exclusive line of cannabis products to the Michigan market through existing licensed operators in the state. Initial products will include flower, vapes, gummies and pre-rolls; pre-orders for Provisioning Centers will commence Wednesday, December 9th.

The limited collection will include distinct offerings, Red Label and Black Label, and will span over 30 High Times® SKUs once fully launched. The product portfolio includes packaged flower, pre-rolls, vapes and edibles offered in value and top shelf varieties. Subject to MRA and lab approvals, the Company expects to see shipments commence in Q1 2021.

"There is no cannabis brand in the world like High Times®," said RWB Chairman & CEO Brad Rogers. "As the most well-known brand in the community, High Times® helped light the way before many of us had even thought about the space. We are on the cusp of a new beginning for both our brands. One that will define RWB and High Times® as the best-in-class for generations to come. We are very excited to bring this important goal to fruition and have plans for many other instantly recognizable High Times® initiatives. With the rights to High Times® and Platinum Vape, RWB has the most recognizable cannabis brands in the market today."

"With a history as vibrant as ours, every move matters, and each new step in a business's roadmap is critical," High Times® Chief Executive Officer Peter Horvath noted. "As the most recognizable brand in cannabis, making the jump into selling actual cannabis products was a huge step in our evolution - but ensuring the proper execution was essential. We're extremely proud and excited to release our collaboration with RWB for the world to consume!"

The Company has exclusive licencing rights to brand dispensaries as well as manufacture and sell cannabis products for the most well-known brand in the industry throughout Michigan. According to data from Headset, recreational sales in Michigan have grown from $9.8 million in January to $65.5 million by August and has already outpaced Nevada to become the fifth highest-grossing state for cannabis sales while on track to surpass $1 billion in sales.

In addition to its rights in Michigan, the Company holds the exclusive licencing rights to brand dispensaries as well as manufacture and sell cannabis products in Illinois and Florida, subject to regulatory approval, and rights to use additional Hightimes Holding Corp's licenses throughout the world for CBD and other non-THC cannabinoids-based products, though not branded as High Times®.

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/investorideas_potcast/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411


Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

Buy a cannabis guest post on Investorideas.com